Oxford Journal of Infectious Diseases (December Supplemental issue 2022 Drop 1 of 3)

In this bumper supplemental issue of the OJID, we have a mixed bag of papers and articles, so let's get straight into it shall we?

1) Reliably Assessing Duration of Protection for Covid19 Vaccines

2) SARS Cov 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)

3) High Attack Rate of SARS Cov 2 B.1.1.529 Among 2-Dose Vaccinated Populations in 2 Indoor Entertainment Setting Outbreaks

4) Cost-effectiveness of Covid19 Vaccination in Low- and Middle-Income Countries

5) Anti-membrane Antibodies Persist at Least One Year and Discriminate Between Past Covid19 Infection and Vaccination

Oxford Journal of Infectious Diseases (December Supplemental issue 2022 Drop 2 of 3)

1) Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough SARS Cov 2 Infection: A Population-Based Longitudinal Study

2) Regimen of Covid19 Vaccination Influences Extent and Kinetics of Antibody Avidity

3) Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution

4) Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort

5) Longitudinal SARS Cov 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G

6) Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine

Oxford Journal of Infectious Diseases (December Supplemental issue 2022 Drop 3 of 3)

1) Predominance of Severe Plasma Leakage in Pediatric Patients With Severe Dengue in Puerto Rico

2) Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine

3) Association of SARS Cov 2 Infection and Related Mortality Rates With Mental Disorders: An Epidemiological Correlation in the Indian Population

3) Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2– Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan

4) Triethylene Glycol Can Be Predeployed as a Safe Virus- Killing Indoor Air Treatment

5) The Number of Covid19 Vaccine Doses and Severe Clinical Outcomes in Older Patients Infected With a SARS Cov 2 Omicron Variant